2CL

64.019997 EUR
0.84
1.33%
Last update Dec 16, 7:30 PM CET
Main market
Day range
62.36000
64.019997
Previous close
63.18000
Open
62.36000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
64.02
0.84
1.33%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 189.1M 9.3M 77.6M 69.7M
Cost of revenue 3.3M 2.4M 3.4M 3.1M
Gross profit 185.8M 6.9M 74.2M 66.6M
Operating expense
Research & development 431.6M 455.7M 399.5M 451.0M
Selling general and admin 246.2M 150.6M 143.2M 192.2M
Other operating expenses
Operating income -492.1M -599.4M -468.4M -576.6M
Non operating interest income
Income 14.7M 18.0M 7.5M 1.1M
Expense 84.6M 81.3M 80.4M 46.8M
Other income expense 99.9M 9.4M 56.7M 35.8M
Pretax income -462.1M -653.3M -484.7M -586.5M
Tax provision 982.6K 0 0
Net income -463.1M -653.3M -484.7M -586.5M
Basic EPS -2.9 -4.0 -3.3 -3.9
Diluted EPS -2.9 -4.0 -3.3 -3.9
Basic average shares 158.6M 169.4M 153.5M 150.2M
Diluted average shares 158.6M 169.4M 153.5M 150.2M
EBITDA -495.2M -574.7M -345.5M -569.7M
Net income from continuing op. -463.1M -653.3M -484.7M -586.5M
Minority interests 7.6M 10.0M 3.5M 23.9M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 47 minutes

11:12
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).